BLACKROCK HEALTH SCIENCES OPPORTUNITIES PORTFOLIO
Name
As of 03/26/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
Vitals
YTD Return
7.2%
1 yr return
15.5%
3 Yr Avg Return
4.5%
5 Yr Avg Return
9.4%
Net Assets
$8.48 B
Holdings in Top 10
47.5%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 1.85%
SALES FEES
Front Load N/A
Deferred Load 1.00%
TRADING FEES
Turnover 19.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$1,000
IRA
N/A
Fund Classification
Fund Type
Open End Mutual Fund
Name
As of 03/26/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
SHSCX - Profile
Distributions
- YTD Total Return 7.2%
- 3 Yr Annualized Total Return 4.5%
- 5 Yr Annualized Total Return 9.4%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio -0.77%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Annual
Fund Details
-
Legal NameBLACKROCK HEALTH SCIENCES OPPORTUNITIES PORTFOLIO
-
Fund Family NameBlackRock
-
Inception DateOct 28, 2002
-
Shares OutstandingN/A
-
Share ClassC
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerErin Xie
Fund Description
SHSCX - Performance
Return Ranking - Trailing
Period | SHSCX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 7.2% | -13.0% | 22.1% | 53.37% |
1 Yr | 15.5% | -19.6% | 37.7% | 52.15% |
3 Yr | 4.5%* | -30.2% | 13.9% | 41.67% |
5 Yr | 9.4%* | -2.8% | 14.5% | 45.59% |
10 Yr | 9.6%* | 0.3% | 14.3% | 47.66% |
* Annualized
Return Ranking - Calendar
Period | SHSCX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | -1.6% | -12.6% | 19.0% | 75.46% |
2022 | -14.4% | -53.9% | 3.2% | 69.23% |
2021 | 0.5% | -39.6% | 24.2% | 49.36% |
2020 | 13.5% | -13.6% | 178.2% | 53.64% |
2019 | 19.3% | 3.8% | 63.8% | 64.44% |
Total Return Ranking - Trailing
Period | SHSCX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 7.2% | -13.0% | 22.1% | 53.37% |
1 Yr | 15.5% | -19.6% | 37.7% | 52.15% |
3 Yr | 4.5%* | -30.2% | 13.9% | 41.67% |
5 Yr | 9.4%* | -2.8% | 14.5% | 45.59% |
10 Yr | 9.6%* | 0.3% | 14.3% | 47.66% |
* Annualized
Total Return Ranking - Calendar
Period | SHSCX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | 2.8% | -12.6% | 19.0% | 73.62% |
2022 | -6.6% | -53.9% | 3.7% | 29.49% |
2021 | 10.9% | -33.9% | 26.0% | 42.31% |
2020 | 18.6% | -0.7% | 180.6% | 64.24% |
2019 | 24.4% | 4.6% | 63.8% | 62.22% |
NAV & Total Return History
SHSCX - Holdings
Concentration Analysis
SHSCX | Category Low | Category High | SHSCX % Rank | |
---|---|---|---|---|
Net Assets | 8.48 B | 6.16 M | 45 B | 6.75% |
Number of Holdings | 124 | 23 | 413 | 12.27% |
Net Assets in Top 10 | 3.77 B | 2.07 M | 20.4 B | 9.20% |
Weighting of Top 10 | 47.49% | 18.1% | 77.0% | 50.92% |
Top 10 Holdings
- UNITEDHEALTH GROUP INC 9.90%
- ELI LILLY CO 9.32%
- BOSTON SCIENTIFIC CORP 4.41%
- MERCK CO. INC. 4.14%
- BLACKROCK LIQUIDITY FUNDS T-FUND PORTFOLIO 3.90%
- AbbVie Inc 3.66%
- AMGEN INC 3.57%
- Danaher Corp 3.06%
- ABBOTT LABORATORIES 2.91%
- GILEAD SCIENCES INC 2.63%
Asset Allocation
Weighting | Return Low | Return High | SHSCX % Rank | |
---|---|---|---|---|
Stocks | 96.00% | 87.17% | 106.13% | 65.03% |
Cash | 4.67% | 0.00% | 32.99% | 31.90% |
Preferred Stocks | 0.01% | 0.00% | 7.86% | 28.83% |
Convertible Bonds | 0.00% | 0.00% | 0.37% | 36.71% |
Bonds | 0.00% | 0.00% | 12.39% | 38.65% |
Other | -0.03% | -22.99% | 17.73% | 96.32% |
Stock Sector Breakdown
Weighting | Return Low | Return High | SHSCX % Rank | |
---|---|---|---|---|
Healthcare | 98.96% | 59.26% | 100.00% | 75.95% |
Basic Materials | 0.73% | 0.00% | 7.16% | 15.19% |
Financial Services | 0.31% | 0.00% | 1.60% | 8.23% |
Utilities | 0.00% | 0.00% | 0.00% | 32.28% |
Technology | 0.00% | 0.00% | 22.69% | 37.97% |
Real Estate | 0.00% | 0.00% | 5.89% | 36.08% |
Industrials | 0.00% | 0.00% | 7.02% | 37.34% |
Energy | 0.00% | 0.00% | 0.00% | 32.28% |
Communication Services | 0.00% | 0.00% | 9.11% | 35.44% |
Consumer Defense | 0.00% | 0.00% | 25.73% | 41.14% |
Consumer Cyclical | 0.00% | 0.00% | 1.92% | 37.34% |
Stock Geographic Breakdown
Weighting | Return Low | Return High | SHSCX % Rank | |
---|---|---|---|---|
US | 93.50% | 66.21% | 104.41% | 43.56% |
Non US | 2.50% | 0.00% | 29.78% | 49.08% |
SHSCX - Expenses
Operational Fees
SHSCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 1.85% | 0.08% | 4.28% | 20.86% |
Management Fee | 0.67% | 0.03% | 1.25% | 47.24% |
12b-1 Fee | 1.00% | 0.00% | 1.00% | 83.33% |
Administrative Fee | 0.07% | 0.03% | 0.25% | 18.42% |
Sales Fees
SHSCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | N/A | 3.50% | 5.75% | N/A |
Deferred Load | 1.00% | 1.00% | 5.00% | 38.10% |
Trading Fees
SHSCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 1.00% | 1.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
SHSCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | 19.00% | 0.00% | 238.00% | 15.22% |
SHSCX - Distributions
Dividend Yield Analysis
SHSCX | Category Low | Category High | SHSCX % Rank | |
---|---|---|---|---|
Dividend Yield | 0.00% | 0.00% | 6.97% | 57.06% |
Dividend Distribution Analysis
SHSCX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Annual | Annually | Annual | Annual |
Net Income Ratio Analysis
SHSCX | Category Low | Category High | SHSCX % Rank | |
---|---|---|---|---|
Net Income Ratio | -0.77% | -2.54% | 1.85% | 82.69% |
Capital Gain Distribution Analysis
SHSCX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Annually | Annually | Annually | Annually |
SHSCX - Fund Manager Analysis
Managers
Erin Xie
Start Date
Tenure
Tenure Rank
Jul 31, 2003
18.85
18.9%
Ms. Xie is the managing director and Portfolio Manager of BlackRock Advisor since 2006. Before becoming part of BlackRock Advisors in 2005, she was with State Street Research & Management since 2001. Ms. Xie began her investment career as a pharmaceutical analyst for Sanford Bernstein in 1999.
Xiang Liu
Start Date
Tenure
Tenure Rank
Jun 01, 2020
2.0
2.0%
Director of BlackRock since 2016. Prior to joining BlackRock in 2008, Mr. Liu was a Partner and Biotech Analyst at Mehta Partners. Mr. Liu began his investment career in 2000 and has a BS from the University of Science & Technology (China), an MBA from the University of Chicago and a PhD degree in Chemistry from Yale University.
Jeff Lee
Start Date
Tenure
Tenure Rank
Jun 01, 2020
2.0
2.0%
Director of BlackRock since 2011. Mr. Lee began his investment career in 2006 and has a BA from Princeton University
Tenure Analysis
Category Low | Category High | Category Average | Category Mode |
---|---|---|---|
0.02 | 24.72 | 7.84 | 0.25 |